Log In
Print
BCIQ
Print
Print this Print this
 

Proleukin, aldesleukin

Also known as: Macrolin

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionInterleukin-2 (IL-2)
Molecular Target Interleukin-2 (IL-2) receptor
Mechanism of ActionInterleukin-2 (IL-2) receptor agonist
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$185.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today